Debevoise Advises Vets First Choice on Financing Aspects of Merger with Henry Schein Animal Health Business

14 February 2019

Debevoise & Plimpton LLP advised Vets First Choice on the financing aspects of its merger with Henry Schein, Inc.’s animal health business. Following the spin-off of Henry Shein’s animal health business and merger with Vets First Choice, the two entities formed a new standalone company: Covetrus.

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. Covetrus is bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Covetrus’ passion for the well-being of animals and those who care for them drives them to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,000 employees, serving over 100,000 customers around the globe.

The Debevoise team is led by partner Scott B. Selinger and associate Ryan T. Rafferty and includes partners Peter A. Furci, Jonathan F. Lewis, Peter J. Loughran and Jeffrey E. Ross, counsels Judith Church and Huey-Fun Lee, and associates Marina Capeto Novello, Douglas M. Hirn, Robert J. Nelson-Sullivan and Michael J. Pisem.

Debevoise & Plimpton LLP is a premier law firm with market-leading practices, a global perspective and strong New York roots. We deliver effective solutions to our clients’ most important legal challenges, applying clear commercial judgment and a distinctively collaborative approach.